Cohance Lifesciences Limited
COHANCE
Rang în acțiuni
#6385
Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a... Headquartered in Hyderabad, Cohance Lifesciences Limited operates as a pharmaceutical enterprise, with primary expertise in contract development and manufacturing (CDMO) services. Its business scope also includes the creation of active pharmaceutical ingredients (APIs) and diverse specialty chemicals. The company, previously known as Suven Pharmaceuticals Limited, underwent a corporate rebranding following its amalgamation with Cohance Lifesciences, a transition officially effective May 1, 2025.
Preț acțiune
$5.05
Ultima sincronizare: 2026-10-19
Capitalizare de piață
$1.93B
Schimbare (1 zi)
-1.44%
Schimbare (1 an)
-57.38%
Țară
IN
Tranzacționează Cohance Lifesciences Limited (COHANCE)
Categorie
Healthcare
Raport P/S pentru Cohance Lifesciences Limited (COHANCE)
Raport P/S la data de October 2026 TTM: 75.08
Conform celor mai recente rapoarte financiare și prețului acțiunilor Cohance Lifesciences Limited, raportul P/S actual (TTM) este 75.08. La sfârșitul anului 2024, compania avea un P/S de 16.21.
Istoricul raportului P/S pentru Cohance Lifesciences Limited din 2019 până în 2026
Raport P/S la sfârșitul fiecărui an
| An | Raport P/S | Schimbă |
|---|---|---|
| 2026 (TTM) | 75.08 | 232.64% |
| 2025 | 22.57 | 39.25% |
| 2024 | 16.21 | 80.67% |
| 2023 | 8.97 | -26.49% |
| 2022 | 12.21 | -5.42% |
| 2021 | 12.91 | 306.97% |
| 2020 | 3.17 | -72.93% |
| 2019 | 11.71 | 0.00% |
Raport P/S pentru companii similare sau competitoare
| Companie | Raport P/S | Diferență raport P/S | Țara |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 7.06 | -90.60% |
IN
|
